Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic impact of Tenofovir Disoproxil Fumarate in HIV-negative healthy adult males
2004-005083-25Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), sponsored by Gilead Sciences. Started Mar 2005; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2004-005083-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005083-25.